Efficient Gene Delivery with Bisphosphonate-Stabilized Calcium Phosphate Nanoparticles

Strategic Insights -

Scientists at the Institute of Pharmaceutical Science in Zurich, Switzerland, have made new discoveries in the field of gene delivery using bisphosphonate-stabilized calcium phosphate nanoparticles. Nucleic acid drugs hold promise for treating a wide range of diseases due to their potential to target specific cells and minimize off-target effects. However, their poor intracellular bioavailability and rapid degradation hinder their development. Researchers have developed various systems to overcome this challenge, with the entrapment of genetic material into nanoparticles being a promising approach.

Key Takeaways:

  • Researchers have developed a versatile, surfactant-free method to stabilize calcium phosphate-DNA nanoparticles using poly(ethylene glycol)-functionalized bisphosphonate.
  • The nanoparticles exhibited physical stability over several days and were around 200 nm in size.
  • The nanoparticles displayed good and sustained ability to transfect cells while showing low toxicity.
  • Calcium phosphate-DNA co-precipitates have been used for gene delivery for over 35 years, offering the advantage of being nontoxic and easy to produce.
  • The use of bisphosphonate-stabilized calcium phosphate nanoparticles represents a promising approach to increase in vitro and in vivo transfection activity.
  • The study demonstrates the potential of this approach for the development of nucleic acid drugs.

Statistics:

  • The researchers used a method to stabilize calcium phosphate-DNA nanoparticles that resulted in particles with a size of around 200 nm.
  • The nanoparticles exhibited physical stability over several days.
  • The study was published in the Journal of Controlled Release in 2011.
  • The researchers concluded that the nanoparticles displayed good and sustained ability to transfect cells while showing low toxicity.
  • Calcium phosphate-DNA co-precipitates have been used for gene delivery for over 35 years.

Sources:

  • Journal of Controlled Release, by E.V. Giger and colleagues, Institute of Pharmaceutical Science, Journal of Controlled Release, 2011;150(1):87-93.
  • Biotech Week, "Gene delivery with bisphosphonate-stabilized calcium phosphate nanoparticles. Journal of Controlled Release, 2011;150(1):87-93."